PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Atrial natriuretic peptide attenuates agonist-induced pulmonary edema in mice with targeted disruption of the gene for natriuretic peptide receptor-A.

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 23195629 ↗2012Reported benefit

Atrial natriuretic peptide attenuates agonist-induced pulmonary edema in mice with targeted disruption of the gene for natriuretic peptide receptor-A.

MouseEndotoxin/LPSNatriuretic peptide receptor-A wild-type, heterozygous and knockout miceInfusionPretreatment before agonist challenge

Model: Acute lung injury and pulmonary oedema induced in anaesthetised mice by thrombin receptor agonist peptide or lipopolysaccharide, with in vitro thrombin-induced loss of transmembrane electrical resistance in pulmonary microvascular endothelial cell monolayers

Pretreatment with atrial natriuretic peptide completely blocked thrombin receptor agonist peptide induced increases in lung wet-to-dry weight and blunted lipopolysaccharide induced increases in lavage cell counts and protein in both NPR-A knockout and wild-type mice. The NPR-C specific ligand cANF…

Extraction: extract · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.